PDB Short entry for 6HVK HEADER PEPTIDE BINDING PROTEIN 11-OCT-18 6HVK TITLE PEPDUCIN UT-PEP2 A BIASED ALLOSTERIC AGONIST OF UROTENSIN-II RECEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: UROTENSIN-2 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UR-2-R,G-PROTEIN COUPLED RECEPTOR 14,UROTENSIN II RECEPTOR, COMPND 5 UR-II-R; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS G PROTEIN-COUPLED RECEPTOR, PEPDUCIN, LIPIDATED PEPTIDE, UROTENSIN II KEYWDS 2 RECEPTOR, ALLOSTERIC MODULATORS, CELLULAR SIGNALING., PEPTIDE KEYWDS 3 BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.CAROTENUTO,T.A.HOANG,H.NASSOUR,R.D.MARTIN,E.BILLARD,L.MYRIAM, AUTHOR 2 E.NOVELLINO,J.C.TANNY,A.FOURNIER,T.E.HEBERT,D.CHATENET REVDAT 3 14-JUN-23 6HVK 1 REMARK LINK ATOM REVDAT 2 15-SEP-21 6HVK 1 JRNL REVDAT 1 30-OCT-19 6HVK 0 JRNL AUTH H.NASSOUR,T.A.HOANG,R.D.MARTIN,J.C.C.DALLAGNOL,E.BILLARD, JRNL AUTH 2 M.LETOURNEAU,E.NOVELLINO,A.CAROTENUTO,B.G.ALLEN,J.C.TANNY, JRNL AUTH 3 A.FOURNIER,T.E.HEBERT,D.CHATENET JRNL TITL LIPIDATED PEPTIDES DERIVED FROM INTRACELLULAR LOOPS 2 AND 3 JRNL TITL 2 OF THE UROTENSIN II RECEPTOR ACT AS BIASED ALLOSTERIC JRNL TITL 3 LIGANDS. JRNL REF J.BIOL.CHEM. V. 297 01057 2021 JRNL REFN ESSN 1083-351X JRNL PMID 34389356 JRNL DOI 10.1016/J.JBC.2021.101057 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT P. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HVK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1200012370. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 2.0 MM 1H PEPTIDE, 200 MM [U-99% REMARK 210 2H] DPC, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1D 1H; 2D 1H-1H NOESY; 2D 1H-1H REMARK 210 TOCSY; 2D DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, XEASY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 1790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 4 HH21 ARG A 8 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 1 ARG A 8 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 2 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 3 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 4 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 4 ARG A 8 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 5 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 6 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 6 ARG A 8 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 7 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 8 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 9 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 10 ARG A 1 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 3 39.81 -79.93 REMARK 500 1 ARG A 8 81.24 -159.69 REMARK 500 1 PRO A 9 -177.55 -68.09 REMARK 500 1 LYS A 10 39.00 -78.24 REMARK 500 2 LEU A 3 40.58 -80.35 REMARK 500 2 ARG A 8 79.57 -160.45 REMARK 500 2 PRO A 9 -178.90 -66.24 REMARK 500 2 LYS A 10 35.40 -74.40 REMARK 500 3 LEU A 3 40.87 -79.99 REMARK 500 3 ARG A 8 80.34 -159.46 REMARK 500 3 PRO A 9 -179.58 -67.72 REMARK 500 3 LYS A 10 38.40 -73.70 REMARK 500 4 LEU A 3 40.21 -87.57 REMARK 500 4 ARG A 8 80.33 -158.84 REMARK 500 4 PRO A 9 -179.36 -67.94 REMARK 500 4 LYS A 10 37.58 -74.61 REMARK 500 5 LEU A 3 38.43 -79.86 REMARK 500 5 ARG A 8 80.22 -159.22 REMARK 500 5 PRO A 9 -178.67 -68.11 REMARK 500 5 LYS A 10 36.69 -74.36 REMARK 500 6 LEU A 3 40.38 -81.68 REMARK 500 6 ARG A 8 79.45 -157.98 REMARK 500 6 PRO A 9 -178.69 -67.82 REMARK 500 6 LYS A 10 36.14 -74.32 REMARK 500 7 LEU A 3 40.23 -82.45 REMARK 500 7 ARG A 8 80.41 -158.78 REMARK 500 7 PRO A 9 -179.54 -68.19 REMARK 500 7 LYS A 10 39.55 -74.22 REMARK 500 8 LEU A 3 40.02 -81.70 REMARK 500 8 ARG A 8 79.39 -160.04 REMARK 500 8 PRO A 9 -179.24 -66.99 REMARK 500 8 LYS A 10 41.42 -76.59 REMARK 500 9 LEU A 3 39.32 -82.04 REMARK 500 9 ARG A 8 79.23 -158.91 REMARK 500 9 PRO A 9 -179.53 -67.59 REMARK 500 9 LYS A 10 37.86 -74.07 REMARK 500 10 LEU A 3 42.09 -79.97 REMARK 500 10 ARG A 8 79.43 -159.38 REMARK 500 10 PRO A 9 -179.64 -67.40 REMARK 500 10 LYS A 10 38.15 -74.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34320 RELATED DB: BMRB REMARK 900 PEPDUCIN UT-PEP2 A BIASED ALLOSTERIC AGONIST OF UROTENSIN-II REMARK 900 RECEPTOR DBREF 6HVK A 0 13 UNP Q9UKP6 UR2R_HUMAN 153 166 SEQADV 6HVK ACE A 0 UNP Q9UKP6 LEU 153 CONFLICT SEQADV 6HVK NH2 A 13 UNP Q9UKP6 ARG 166 CONFLICT SEQRES 1 A 14 ACE ARG PRO LEU ASP THR VAL GLN ARG PRO LYS GLY TYR SEQRES 2 A 14 NH2 HET ACE A 0 6 HET NH2 A 13 3 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N LINK C ACE A 0 N ARG A 1 1555 1555 1.33 LINK C TYR A 12 N NH2 A 13 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000